News

The Immune System and Atopic Dermatitis


 

Elif Dokmeci, MD, and Christina A. Herrick, MD, PhD

Atopic dermatitis (AD) is a chronic inflammatory skin disease with a complex pathogenesis. It is clinically well-defined and represents one manifestation of the atopic state, along with asthma, food allergy and/or allergic rhinitis. Within the last several decades, there has been much evidence to support the contribution of immune mechanisms in the pathogenesis of AD. It has also been documented that the prevalence of all atopic disease, including AD, has been increasing, although the environmental factors that may be contributing to this increase are not clearly defined. A better understanding of the underlying immunopathogenesis of AD should aid in better clinical management and development of new treatment options.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Tacrolimus Comes Out on Top for Treating Atopy
MDedge Dermatology
Long-Term Use of Tacrolimus for AD Flares Found to Reduce Relapse Risk
MDedge Dermatology
Web Use May Be Reason for Eczema Patient's Steroid Fear
MDedge Dermatology
Topical Therapy in Pediatric Atopic Dermatitis
MDedge Dermatology
Pediatric Atopic Dermatitis: The Importance of Food Allergens
MDedge Dermatology
Atopic Dermatitis: Systemic Immunosuppressive Therapy
MDedge Dermatology
Antimicrobial Peptides, Skin Infections, and Atopic Dermatitis
MDedge Dermatology
Patchy Eczema of Elderly Patients [editorial]
MDedge Dermatology
The Effect of Ceramide-Containing Skin Care Products on Eczema Resolution Duration
MDedge Dermatology
A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses
MDedge Dermatology